切换至 "中华医学电子期刊资源库"

中华肺部疾病杂志(电子版) ›› 2022, Vol. 15 ›› Issue (03) : 339 -343. doi: 10.3877/cma.j.issn.1674-6902.2022.03.011

论著

广州地区非结核分枝杆菌肺病微生物及临床特征分析
赖宁1,(), 庄泽钦1, 钟典1   
  1. 1. 510120 广州,广州医科大学附属第一医院,广州呼吸健康研究院,呼吸疾病国家重点实验室,国家呼吸系统疾病临床医学研究中心
  • 收稿日期:2021-10-05 出版日期:2022-06-25
  • 通信作者: 赖宁

Analysis of microbiological and clinical characteristic of non-tuberculous Mycobacteria related pulmonary diseases in Guangzhou

Ning Lai1,(), Zeqin Zhuang1, Dian Zhong1   

  1. 1. The First Affiliated Hospital of Guangzhou Medical University, Guangzhou Institute of Respiratory Health, State Key Laboratory of Respiratory Disease, National Clinical Research Center for Respiratory Disease, Guangzhou 510120, China
  • Received:2021-10-05 Published:2022-06-25
  • Corresponding author: Ning Lai
引用本文:

赖宁, 庄泽钦, 钟典. 广州地区非结核分枝杆菌肺病微生物及临床特征分析[J]. 中华肺部疾病杂志(电子版), 2022, 15(03): 339-343.

Ning Lai, Zeqin Zhuang, Dian Zhong. Analysis of microbiological and clinical characteristic of non-tuberculous Mycobacteria related pulmonary diseases in Guangzhou[J]. Chinese Journal of Lung Diseases(Electronic Edition), 2022, 15(03): 339-343.

目的

分析广州地区不同非结核分枝杆菌(NTM)与其所致肺病的临床特征。

方法

选择2016年1月至2020年12月广州地区的112例NTM肺病患者,分析NTM患者的症状、影像学特征及易感因素。

结果

112例NTM肺病患者中,男性年龄>50岁占78.7%(48/61),女性年龄>50岁占84.3%(43/51),NTM感染与患者年龄高度相关(r=0.16,P=0.018)。胞内分枝杆菌80例(71.4%)。男性患者更易出现咳嗽症状(48/61)(χ2=3.27,P=0.03),而女性患者更易出现咯血症状(14/51)(χ2=5.39,P=0.021)。年龄大的患者更易出现咯血(16/91)(r=0.21,P=0.015),而年轻患者更易出现气短症状(10/21)(r=0.17,P=0.023)。NTM肺部疾病最常见的影像学特征是支气管扩张,占40.2%(45/112),肺部结节占36.6%(41/112),多发空洞38.4%(43/112)。NTM感染最常见的易患因素为MTB,占66.1%(74/112);其次为支气管扩张占25.0%(28/112),合并COPD占17.9%(20/112)。与女性患者相比,男性患者更易合并COPD(OR=5.23,95%CI 5.20~72.60);胞内分枝杆菌感染更易合并支气管扩张(OR=0.13,95%CI 0.09~0.86)。

结论

广州地区NTM感染最常见的病原体是胞内分枝杆菌。NTM感染与患者年龄相关,最常见的影像学表现是支气管扩张、结节影及多发性空洞。MTB感染及器官移植是NTM感染的高危因素。

Objective

To analyze the clinical characteristic relevance between different non-tuberculous mycobacteria (NTM) and NTM related pulmonary diseases (NTM-PD) in Guangzhou.

Methods

We performed a retrospective analysis of 112 NTM-PD patients in Guangzhou from January 2016 to December 2020, analyzing the symptom, radiological characteristic, and risk factor of all NTM-PD patients.

Results

In all 112 NTM-PD patients, the age of 78.7% (48/61) male patients and 84.3% (43/51) female patients was over 50. NTM infection was also highly related with the age of patient (r=0.16, P=0.018). 71.4% (80) patients were infected with M. intracellulare in all 112 NTM-PD patients. Male patients (61) were more likely to have cough (48) (χ2=3.27, P=0.03), but female patients (51) were more likely to have hemoptysis (14) (χ2=5.39, P=0.021). The older patients (91) were more likely to have hemoptysis (16) (r=0.21, P=0.015) , but the younger patients (21) were more likely to have shortness of breath (10) (r=0.17, P=0.023). The most common radiological presentation of NTM-PD was bronchiectasis 40.2% (45/112), pulmonary nodule 36.6% (41/112), multiple cavities 38.4% (43/112). The most common risk factor of NTM infection was tuberculosis 66.1% (74/112), bronchiectasis 25.0% (28/112), COPD 17.9% (20/112). Compared with female patients, male patients were more likely to have COPD (OR=5.23, 95%CI 5.20~72.60). The patients infected with M. intracellulare were more likely to have bronchiectasis (OR=0.13, 95%CI 0.09~0.86).

Conclusion

The most common pathogenic NTM species was M. intracellulare in Guangzhou. NTM infection was highly related with the age of patient. The most common radiological presentation of NTM-PD was bronchiectasis, pulmonary nodule, and multiple cavities. Tuberculosis infection and organ transplantation were also high risk factor of NTM infection.

表1 112例广州地区NTM肺病患者的病原体分布情况(n)
表2 112例NTM肺病患者的临床症状与不同NTM之间的关系(n)
表3 112例NTM肺病患者的影像学表现与不同种类NTM之间的关系(n)
表4 易感因素与不同NTM之间的关系(n)
表5 NTM感染和NTM定植患者的临床特征、影像学特征和易患因素比较
1
Diagnosis and treatment of disease caused by nontuberculous mycobacteria. This official statement of the american thoracic society was approved by the board of directors, march 1997. Medical section of the american lung association[J]. Am J Respir Crit Care Med, 1997, 156(2 Pt 2): S1-S25.
2
D Rebecca Prevots, Pamela AS, Daniel S, et al. Nontuberculous mycobacterial lung disease prevalence at four integrated health care delivery systems[J]. Am J Respir Crit Care Med, 2010182(7): 970-976.
3
Seung JK, Soon PS. Increasing burden of nontuberculous Mycobacteria in Korea[J]. J Korean Med Sci, 2017, 32(8): 1215-1216.
4
Ho N, Atsuyuki K, Kozo M, et al. Epidemiology of pulmonary nontuberculous Mycobacterial disease, Japan[J]. Emerg Infect Dis, 2016, 22(6): 1116-1117.
5
David EG, Timothy A, Brown-Elliott Barbara A,et al. An official ATS/IDSA statement: diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases[J]. Am J Respir Crit Care Med, 2007, 175(4): 367-416.
6
赵雁林,逄 宇. 结核病实验室检验规程[M]. 北京:人民卫生出版社,2015: 38-42.
7
Reich JM, Johnson RE. Mycobacterium avium complex pulmonary disease presenting as an isolated lingular or middle lobe pattern. The Lady Windermere syndrome[J]. Chest, 1992, 101(6): 1605-1609.
8
Neeraj MS, Jennifer AD, Laura FA, et al. Pulmonary Mycobacterium avium-intracellulare is the main driver of the rise in non-tuberculous mycobacteria incidence in England, Wales and Northern Ireland, 2007-2012[J]. BMC Infect Dis, 2016, 16: 195.
9
Duan HF, Han XQ, Wang QF, et al. Clinical significance of nontuberculous Mycobacteria isolated from respiratory specimens in a chinese tuberculosis tertiary care center[J]. Sci Rep, 2016, 3(6): 36299.
10
Furuuchi K, Ito A, Hashimoto T, et al. Clinical significance of the radiological severity score in Mycobacterium avium complex lung disease patients[J]. Int J Tuberc Lung Dis, 2017, 21(4): 452-457.
11
Jennifer A, Kenneth NO, D Rebecca Prevots. Nontuberculous mycobacteria among patients with cystic fibrosis in the United States: screening practices and environmental risk[J]. Am J Respir Crit Care Med, 2014, 190(5): 581-586.
12
van Ingen J, Bendien SA, de Lange WCM, et al. Clinical relevance of non-tuberculous mycobacteria isolated in the Nijmegen-Arnhem region, The Netherlands[J]. Thorax, 2009, 64(6): 502-506.
13
Giulia B, Alberto P, Almerico M, et al. Nontuberculous Mycobacteria in noncystic fibrosis bronchiectasis[J]. Biomed Res Int, 2015, 2015: 197950.
14
Chu HQ, Zhao L, Xiao HQ, et al. Prevalence of nontuberculous mycobacteria in patients with bronchiectasis: a meta-analysis[J]. Arch Med Sci, 2014, 10(4): 661-668.
15
Jennifer RH, Vijaya K, Edward DC. Pathogenesis and risk factors for nontuberculous mycobacterial lung disease[J]. Clin Chest Med, 2015, 36(1): 1-11.
16
Chan Edward D, Iseman Michael D. Underlying host risk factors for nontuberculous mycobacterial lung disease[J]. Semin Respir Crit Care Med, 2013, 34(1): 110-123.
17
Jennifer B, Elizabeth S, Fotios VM, et al. Incidence and risk factors for nontuberculous Mycobacterial infection after allogeneic hematopoietic cell transplantation[J]. Biol Blood Marrow Transplant, 2018, 24(2): 366-372.
18
F O′Toole R, Shukla SD, Walters EH. TB meets COPD: An emerging global co-morbidity in human lung disease[J]. Tuberculosis (Edinb), 2015, 95(6): 659-663.
19
Emily H, Kevin LW. Nontuberculous mycobacteria infections in immunosuppressed hosts[J]. Clin Chest Med, 2015, 36(1): 91-99.
20
Martiniano SL, Nick JA, Daley CL. Nontuberculous Mycobacterial infections in cystic fibrosis[J]. Thorac Surg Clin, 2019, 29(1): 95-108.
21
Martiniano SL, Nick JA, Daley CL. Nontuberculous Mycobacterial Infections in Cystic Fibrosis[J]. Clin Chest Med, 2016, 37(1): 83-96.
22
Adjemian J, Olivier KN, Prevots DR. Epidemiology of pulmonary nontuberculous Mycobacterial sputum positivity in patients with cystic fibrosis in the united States, 2010-2014[J]. Ann Am Thorac Soc, 2018, 15(7): 817-826.
23
Bar-On O, Mussaffi H, Mei-Zahav M, et al. Increasing nontuberculous mycobacteria infection in cystic fibrosis[J]. J Cyst Fibros, 2015, 14(1): 53-62.
24
Martiniano SL, Esther CR, Haworth CS, et al. Challenging scenarios in nontuberculous mycobacterial infection in cystic fibrosis[J]. Pediatr Pulmonol, 2020, 55(2): 521-525.
25
Lu M, Saddi V, Britton PN, et al. Disease caused by non-tuberculous mycobacteria in children with cystic fibrosis[J]. Paediatr Respir Rev, 2019, 29: 42-52.
[1] 王月丽, 宋砾, 牛宝荣, 陈炎, 张楠, 何怡华. 心脏血管肉瘤的临床及超声心动图特征[J]. 中华医学超声杂志(电子版), 2023, 20(04): 398-403.
[2] 缪黄泰, 李潇颖, 张明, 聂绍平. 急性心肌梗死后心脏破裂患者院内死亡的危险因素分析[J]. 中华危重症医学杂志(电子版), 2023, 16(03): 187-192.
[3] 董晓燕, 赵琪, 唐军, 张莉, 杨晓燕, 李姣. 奥密克戎变异株感染所致新型冠状病毒感染疾病新生儿的临床特征分析[J]. 中华妇幼临床医学杂志(电子版), 2023, 19(05): 595-603.
[4] 王胜男, 孙挥宇, 接英, 谢雯, 毛菲菲, 李丹, 鲁丹, 刘夕瑶. 慢性丙型肝炎患者干眼临床特征[J]. 中华实验和临床感染病杂志(电子版), 2023, 17(01): 48-54.
[5] 刘麒, 曾弘, 徐子昕, 方超, 黄铭, 郑俊炯, 吴少旭, 钟广正, 林天歆, 黄健, 董文. 乳头状肾细胞癌单中心11年临床诊治与预后分析[J]. 中华腔镜泌尿外科杂志(电子版), 2023, 17(04): 351-355.
[6] 李小娟, 李炜佳, 彭凌燕, 周鹏莹, 李桂娥, 刘相辰. 体检人群中前列腺钙化灶的检出率及临床特征分析[J]. 中华腔镜泌尿外科杂志(电子版), 2023, 17(04): 336-338.
[7] 孟原竹, 蒋国路, 陈小兵, 蒋莉. 肺结核合并侵袭性肺曲霉感染临床特征及危险因素分析[J]. 中华肺部疾病杂志(电子版), 2023, 16(04): 541-543.
[8] 李华娟, 唐英俊, 王赛妮, 徐旺, 林玲, 李羲, 黄华萍. 肺结节临床与CT影像学特征分析及良恶性预测模型构建[J]. 中华肺部疾病杂志(电子版), 2023, 16(03): 318-323.
[9] 田井梅, 何俊, 何永琴, 张玉梅, 郑文红, 袁玉霞. 老年慢性阻塞性肺疾病合并髋部骨折围术期31例临床特征分析[J]. 中华肺部疾病杂志(电子版), 2023, 16(03): 418-420.
[10] 李雅丽, 薛敏君, 韩福. 38例肺隐球菌患者CT及临床特征分析[J]. 中华肺部疾病杂志(电子版), 2023, 16(02): 236-238.
[11] 王欣, 孙丹琦, 黄瑾瑜. 高分辨弥散加权成像ADC直方图参数与直肠癌临床特征相关性的回顾性研究[J]. 中华结直肠疾病电子杂志, 2023, 12(02): 132-138.
[12] 宋璇, 刘新艳, 杨大强, 杨茂鹏, 秦冰新, 田首成, 郭秀燕, 刘紫微, 王春亭. 肺超声弹性成像在肺部疾病中的应用进展[J]. 中华临床医师杂志(电子版), 2023, 17(02): 215-219.
[13] 王红权, 詹杰, 彭春晓, 梅振华, 邹亮. 肠白塞病的研究进展[J]. 中华临床医师杂志(电子版), 2023, 17(02): 220-226.
[14] 曹箫笛, 王哲. 异常P波额面电轴对不同疾病死亡风险的预测价值[J]. 中华心脏与心律电子杂志, 2023, 11(01): 12-17.
[15] 苏琪皓, 解利红, 孟宪梅, 王觅柱, 王晶, 张静洁, 汤泊夫, 江振宇. 消化道毛细血管扩张特征及内镜治疗效果观察[J]. 中华胃肠内镜电子杂志, 2023, 10(03): 180-184.
阅读次数
全文


摘要